These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Rhéaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F. Nat Genet; 1992 Jul; 1(4):239-45. PubMed ID: 1363812 [Abstract] [Full Text] [Related]
8. A family at risk of congenital adrenal hyperplasia: a molecular approach for prenatal diagnosis. Ruangvutilert P, Techatraisak K, Kanokpongsakdi S. J Med Assoc Thai; 2001 Dec; 84(12):1766-71. PubMed ID: 11999826 [Abstract] [Full Text] [Related]
15. COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications. Mauger F, How-Kit A, Tost J. Mol Diagn Ther; 2017 Jun; 21(3):269-283. PubMed ID: 28101802 [Abstract] [Full Text] [Related]
17. Non-invasive prenatal molecular detection of a fetal point mutation for congenital adrenal hyperplasia using co-amplification at lower denaturation temperature PCR. Du J, Zou X, Pan Y, Li SF, Lu GX. Chin Med J (Engl); 2010 Nov; 123(22):3343-6. PubMed ID: 21163141 [No Abstract] [Full Text] [Related]